Showing results (1761-1770 of 1,927) with videos related to

Sort By:
Pageof 193
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2020
Risk Factors for Healthcare Personnel Infection With Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT)Derek A T Cummings, Lewis J Radonovich, Geoffrey J Gorse, et al.
American Journal of Obstetrics and Gynecology|February 26, 2022
Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group studyPhuong L Mai, Austin Miller, Amanda Black, et al.
Leukemia|June 19, 2012
Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemiaM C Chillón, M T Gómez-Casares, C E López-Jorge, et al.
Journal of Substance Abuse Treatment|September 22, 2019
Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trialE Jennifer Edelman, Stephen A Maisto, Nathan B Hansen, et al.
Open Forum Infectious Diseases|August 19, 2015
Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patientsKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
Contemporary Clinical Trials|May 25, 2023
Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trialE Jennifer Edelman, James Dziura, Yanhong Deng, et al.
Journal of the International AIDS Society|March 22, 2016
Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South AmericaCarina Cesar, John R Koethe, Mark J Giganti, et al.
Cancer Immunology Research|January 20, 2026
Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T cells Antitumor Immunity Through Metabolic ReprogrammingPhaethon Philbrook, Matthew J Dean, Maria Dulfary Sanchez-Pino, et al.
Gynecologic Oncology|November 25, 2019
Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG studyPhuong L Mai, Helen Q Huang, Lari B Wenzel, et al.
Pageof 193